10-Q/A XBRL

10-Q/A

Company: Protalix BioTherapeutics, Inc.
Filed: March 18, 2019
Period of Report: June 30, 2018
Accession Number: 0001144204-19-014453

View Document ↗ View on SEC.gov ↗